Literature DB >> 5311915

Failure of trasylol to reduce intestinal content of trypsin and chymotrypsin in man.

D M Goldberg, R Campbell, A D Roy.   

Abstract

The daily output of trypsin and chymotrypsin was measured in the stools of four patients with an established ileostomy under controlled dietary and metabolic conditions for a control period of four days. Trasylol, given intravenously in a dose of 500,000 units over eight hours, failed to affect the output of enzymes over the next two days, or to alter the distribution of bound and soluble enzymes.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5311915      PMCID: PMC1553098          DOI: 10.1136/gut.11.8.697

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  Effect of diet on the trypsin and chymotrypsin output in the stools of patients with an ileostomy.

Authors:  A D Roy; R Campbell; D M Goldberg
Journal:  Gastroenterology       Date:  1967-10       Impact factor: 22.682

2.  Activation, inhibition and protection of tryptic and alpha-chymotryptic activity by normal human serum.

Authors:  J Bieth; P Metais; J Warter
Journal:  Clin Chim Acta       Date:  1968-04       Impact factor: 3.786

3.  The treatment of experimentally induced acute pancreatitis.

Authors:  G A Kune
Journal:  Aust N Z J Surg       Date:  1968-11

4.  Proteinase inhibitors in acute pancreatitis.

Authors:  K Hansson; S Lenninger
Journal:  Acta Chir Scand Suppl       Date:  1967

5.  Aprotinin therapy as prophylaxis against postoperative pancreatitis in humans. A controlled evaluation.

Authors:  D B Skinner; J G Corson; G L Nardi
Journal:  JAMA       Date:  1968-06-10       Impact factor: 56.272

6.  A clinical trial of an enzyme inhibitor in pancreatitis.

Authors:  J J Kneisel
Journal:  Arch Surg       Date:  1968-03

7.  Proteinase inhibitor and treatment of acute pancreatitis. An experimental study.

Authors:  L dos Reis
Journal:  Am Surg       Date:  1967-04       Impact factor: 0.688

8.  Postoperative changes in the trypsin inhibitor activities of human pancreatic juice and the influence of infusion of Trasylol on the inhibitor activity.

Authors:  A Morgan; L A Robinson; T T White
Journal:  Am J Surg       Date:  1968-02       Impact factor: 2.565

9.  Trasylol in acute pancreatitis.

Authors:  J E Trapnell; C H Talbot; W M Capper
Journal:  Am J Dig Dis       Date:  1967-04

10.  Serum esterolytic activity in a wide variety of diseases. With special reference to pancreatic and liver disease.

Authors:  V W Groisser; F Raugh; M Floch; J Bobruff
Journal:  N Engl J Med       Date:  1966-01-20       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.